Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ashdown

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
BJU International|December 12, 2007
Serendipity in urologyGraham Young, Daniel Ashdown, Andrew Arnold, et al.
Springerplus|September 18, 2015
Erratum to: The effectiveness of varicocele embolisation for the treatment of varicocele related orchalgiaDavid W Muthuveloe, Vinnie During, Daniel Ashdown, et al.
Springerplus|August 8, 2015
The effectiveness of varicocele embolisation for the treatment of varicocele related orchalgiaDavid W Muthuveloe, Vinnie During, Daniel Ashdown, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2009
A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984]Prashant Patel, J Graham Young, Vivien Mautner, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
BJU International|December 12, 2007
Serendipity in urologyGraham Young, Daniel Ashdown, Andrew Arnold, et al.
Springerplus|September 18, 2015
Erratum to: The effectiveness of varicocele embolisation for the treatment of varicocele related orchalgiaDavid W Muthuveloe, Vinnie During, Daniel Ashdown, et al.
Springerplus|August 8, 2015
The effectiveness of varicocele embolisation for the treatment of varicocele related orchalgiaDavid W Muthuveloe, Vinnie During, Daniel Ashdown, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2009
A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984]Prashant Patel, J Graham Young, Vivien Mautner, et al.
Pageof 1